{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T23:42:38Z","timestamp":1648683758529},"reference-count":10,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2015,5,4]]},"DOI":"10.3109\/10428194.2014.975701","type":"journal-article","created":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T14:17:35Z","timestamp":1413814655000},"page":"1554-1555","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["The current situation and future aspects of cost-effectiveness in chronic myeloid leukemia treatment"],"prefix":"10.1080","volume":"56","author":[{"given":"Ahmet Emre","family":"Eskazan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teoman","family":"Soysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,11,19]]},"reference":[{"key":"CIT0001","volume-title":"Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib","author":"Ohm L","year":"2014"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4377-1604-7.00190-1"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-490003"},{"key":"CIT0005","author":"Soysal T","year":"2014","journal-title":"Expert Rev Hematol"},{"key":"CIT0006","author":"Eskazan AE","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12937"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.90"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70233-3"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-483750"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-501569"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2014.975701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T17:48:41Z","timestamp":1481824121000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428194.2014.975701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,19]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,11,3]]},"published-print":{"date-parts":[[2015,5,4]]}},"alternative-id":["10.3109\/10428194.2014.975701"],"URL":"https:\/\/doi.org\/10.3109\/10428194.2014.975701","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}